๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Embryonal Tumor

Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma NCT04594187Phase 23 sites๐Ÿ“ Jacksonville๐Ÿ“ Camden๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Immunotherapy, Quality-of-Life Assessment, Radiation Therapy Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients NCT03546387n/a1 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V), California Verbal Learning Test, Children's Versโ€ฆ Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma NCT07452458Phase 354 sites๐Ÿ“ Irvine๐Ÿ“ Los Angeles๐Ÿ“ Orange NRG Oncology ยท Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Questionnaire Administration, Radiation Therapy A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site๐Ÿ“ Shanghai Hansoh BioMedical R&D Company ยท Tests: HS-20108 Monotherapy Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients NCT04765514Phase 22 sites๐Ÿ“ Calgary๐Ÿ“ Edmonton AHS Cancer Control Alberta ยท Tests: Temozolomide monotherapy, Chemo-Radiotherapy with concurrent temozolomide. A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies NCT04678648Phase 13 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ Nashville RasCal Therapeutics, Inc. ยท Tests: RSC-1255 Dose Escalation, RSC-1255 Dose Expansion An International Study on Pediatric Patients With Rare Tumors. NCT07072143n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma NCT07704918NA1 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolโ€ฆ DermaSensor Postmarket Surveillance Study NCT06666790NA2 sites๐Ÿ“ New Smyrna Beach๐Ÿ“ Morehead City DermaSensor, Inc. ยท Tests: Scan with elastic scattering spectroscopy device to assess risk of malignancy Sonodynamic Therapy in Patients With Recurrent GBM NCT06039709Phase 11 site๐Ÿ“ Charlottesville Shayan Moosa, MD ยท Tests: 5-ALA and Low-Intensity Focused Ultrasound (SDT) A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naรฏve Adult Patients With Metastatic Uveal Melanoma NCT06581406Phase 2, Phase 333 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Replimune, Inc. ยท Tests: RP2, Ipilimumab, Nivolumab A Study of IBI363 in Subjects With Advanced Melanoma NCT06081920Phase 212 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Fuzhou Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI363 Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia NCT07422779NA1 site๐Ÿ“ Ljubljana Institute of Oncology Ljubljana ยท Tests: Pembrolizumab, Nivolumab, Ipilimumab A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas NCT07003542Phase 21 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Sitagliptin A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site๐Ÿ“ Louisville University of Louisville ยท Tests: Vemurafenib, Metformin Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites๐Ÿ“ Berlin๐Ÿ“ Cologne๐Ÿ“ Erlangen Miltenyi Biomedicine GmbH ยท Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence NCT04215211n/a1 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: Survival prediction for glioma patients TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 68Ga-SorB PET/CT A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01) NCT07202728n/a14 sites๐Ÿ“ Lanzhou๐Ÿ“ Shenzhen๐Ÿ“ Haikou Obstetrics & Gynecology Hospital of Fudan University ยท Tests: No intervention The NF Registry Sponsored by the Children's Tumor Foundation NCT01885767n/a1 site๐Ÿ“ New York The Children's Tumor Foundation Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients NCT04917484Phase 21 site๐Ÿ“ Aarhus Tine Gregersen, MD ยท Tests: Lu-177-DOTA-Octreotide Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study NCT07354152n/a1 site๐Ÿ“ Nantes Nantes University Hospital The MELAcare Study: A New Method for Surveillance of Melanoma Patients NCT05253872NA1 site๐Ÿ“ Copenhagen Herlev and Gentofte Hospital ยท Tests: The MelaCare intervention Predictive Value of Soluble CD146 in Glioblastoma Patients NCT06001281NA1 site๐Ÿ“ Marseille Assistance Publique Hopitaux De Marseille ยท Tests: plasma collection Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rฮฑ2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas NCT07544992Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells, Biopsy Procedure, Biospecimen Collection, Echocardiography Test, FDGโ€ฆ Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma NCT07884344EARLY Phase 11 site๐Ÿ“ Miami Macarena De La Fuente, MD ยท Tests: Lixumistat - Cohort 1, Lixumistat - Cohort 2
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy